MG:NYSEMistras Group Inc Analysis
Data as of 2026-06-12 - not real-time
$18.82
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
MG is trading at $18.82, just below the calculated resistance of $19.24 and comfortably above the support of $16.40. The 20‑day SMA (17.75) sits marginally above the 50‑day SMA (17.69) and both are well above the 200‑day SMA (13.67), confirming a bullish price structure. Technical momentum is reinforced by an RSI of 59 and a bullish MACD histogram of 0.10, indicating continued upward pressure. Volatility is elevated at 44.5% over the past 30 days and beta of 1.32 points to higher systematic risk relative to the market. Nonetheless, the Fear & Greed Index reads "Extreme Greed" (88.95), suggesting strong investor appetite.
Fundamentals back the technical picture – Q1 revenue rose 4.6% to $731 M, gross margin expanded by 120 bps and EPS beat expectations at $0.07, driving a 75% earnings surprise. The forward PE of 15.1 is well below the industry average of 30.6, and the current PE of 26.9 signals a modest discount, giving an upside potential of roughly 12% to the consensus $21 target. The balance sheet is a concern: debt‑to‑equity stands at 107% and total debt ($251 M) exceeds cash on hand, raising leverage risk. The company pays no dividend, so income‑focused investors must rely on price appreciation. Overall, MG presents a growth‑oriented, yet risk‑weighted, investment case.
Fundamentals back the technical picture – Q1 revenue rose 4.6% to $731 M, gross margin expanded by 120 bps and EPS beat expectations at $0.07, driving a 75% earnings surprise. The forward PE of 15.1 is well below the industry average of 30.6, and the current PE of 26.9 signals a modest discount, giving an upside potential of roughly 12% to the consensus $21 target. The balance sheet is a concern: debt‑to‑equity stands at 107% and total debt ($251 M) exceeds cash on hand, raising leverage risk. The company pays no dividend, so income‑focused investors must rely on price appreciation. Overall, MG presents a growth‑oriented, yet risk‑weighted, investment case.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (SMA crossover, MACD, RSI)
- Q1 earnings beat and margin expansion
- Price near support with upside to target
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained revenue growth in aerospace & defense
- Elevated leverage and debt levels
- Forward PE indicating undervaluation
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Diversified global footprint exposing currency risk
- High beta and volatility increasing systematic risk
- No dividend requiring reliance on capital appreciation
Key Metrics & Analysis
Financial Health
Revenue Growth4.60%
Profit Margin3.06%
P/E Ratio26.9
ROE10.38%
ROA6.33%
Debt/Equity107.46
P/B Ratio2.6
Op. Cash Flow$30.1M
Free Cash Flow$2.9M
Industry P/E30.6
Technical Analysis
TrendBullish
RSI59.2
Support$16.40
Resistance$19.24
MA 20$17.75
MA 50$17.69
MA 200$13.67
MACDBullish
VolumeStable
Fear & Greed Index88.95
Valuation
Target Price$21.00
Upside/Downside11.58%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.32
Volatility44.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.